Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China · Delayed Price · Currency is CNY 31.02
-1.16 (-3.60%)
Jul 30, 2026, 12:20 PM CST
SHE:300584 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 688.74 | 671.05 | 504.36 | 517.83 | 526.47 | 578.32 |
Revenue Growth | 26.97% | 33.05% | -2.60% | -1.64% | -8.97% | -18.12% |
Gross Profit Gross Profit Growth | 549.83 | 546.86 | 411.29 | 416.56 | 392.68 | 468.39 |
Operating Income Operating Income Growth | 80.01 | 82.06 | 52.4 | 45.94 | 34.63 | 29.41 |
Net Income Net Income Growth | 44.38 | 42.06 | 40.22 | 36.32 | 32.45 | 285.88 |
Earnings Per Share EPS Growth | 0.37 | 0.35 | 0.34 | 0.30 | 0.27 | 2.38 |
EPS Growth | 5.96% | 4.60% | 10.74% | 11.91% | -88.65% | 417.55% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Northeast China Region Northeast China Region Growth | 23.2 | 16.55 | 19.98 | 27.58 | 56.56 |
North China North China Growth | 187.39 | 108.46 | 81.56 | 73.47 | 80.15 |
East China East China Growth | 256.82 | 191.31 | 220.46 | 238.87 | 249.78 |
Southern China Southern China Growth | 64.35 | 48.76 | 40.77 | 30.93 | 32.27 |
Central China Region Central China Region Growth | 62.59 | 47.8 | 46.91 | 46.24 | 53.96 |
Northwestern Region Northwestern Region Growth | 29.86 | 24.29 | 24.59 | 30.74 | 31.63 |
Southwest Region Southwest Region Growth | 46.84 | 67.19 | 81.71 | 74.91 | 66.46 |
Total Total Growth | 671.05 | 504.36 | 517.83 | 526.47 | 578.32 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 71.23 | 66.19 | 45.76 | 46.82 | 95.07 | 115.6 |
Total Debt Total Debt Growth | 296.2 | 286.73 | 314.74 | 271 | 178.15 | 180.28 |
Net Cash (Debt) Net Cash Growth | -224.97 | -220.54 | -268.98 | -224.18 | -83.09 | -64.68 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.87 | -1.84 | -2.24 | -1.87 | -0.69 | -0.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 45.54 | 78.09 | 59.96 | 23.93 | -5.82 | 59.94 |
Capital Expenditures CapEx Growth | -48.6 | -62.64 | -77.94 | -197.22 | -218.94 | -94.41 |
Free Cash Flow Free Cash Flow Growth | -3.06 | 15.45 | -17.98 | -173.29 | -224.76 | -34.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 79.83% | 81.49% | 81.55% | 80.44% | 74.59% | 80.99% |
Operating Margin | 11.62% | 12.23% | 10.39% | 8.87% | 6.58% | 5.09% |
Pretax Margin | 6.67% | 7.05% | 8.14% | 7.28% | 5.47% | 57.14% |
Profit Margin | 6.44% | 6.27% | 7.97% | 7.01% | 6.16% | 49.43% |
FCF Margin | -0.44% | 2.30% | -3.56% | -33.46% | -42.69% | -5.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.050 | - | 0.250 |
Dividend Per Share Growth | 0% | 0% | 100.00% | - | - | 100.00% |
Dividend Yield | 0.31% | 0.20% | 0.50% | 0.22% | - | 1.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 87.00 | 143.29 | 60.15 | 76.93 | 119.08 | 8.40 |
Forward PE | - | 26.20 | 26.20 | 26.20 | 26.20 | 26.20 |
P/FCF Ratio | - | 390.08 | - | - | - | - |
PS Ratio | 5.61 | 8.98 | 4.80 | 5.40 | 7.34 | 4.15 |